These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical, epidemiologic, and pulmonary function studies in alpha,-antitrypsin-deficient subjects of Pi Z type. Rawlings W; Kreiss P; Levy D; Cohen B; Menkes H; Brashears S; Permutt S Am Rev Respir Dis; 1976 Nov; 114(5):945-53. PubMed ID: 1086622 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal lung function study in heterozygous PiMZ phenotype subjects. Tarján E; Magyar P; Váczi Z; Lantos A; Vaszár L Eur Respir J; 1994 Dec; 7(12):2199-204. PubMed ID: 7713204 [TBL] [Abstract][Full Text] [Related]
5. Heterozygous alpha 1-antitrypsin deficiency: a longitudinal lung function study. de Hamel FA; Carrell RW N Z Med J; 1981 Dec; 94(697):407-10. PubMed ID: 6977750 [TBL] [Abstract][Full Text] [Related]
6. Lung distensibility and airway function in intermediate alpha 1-antitrypsin deficiency (Pi MZ). Tattersall SF; Pereira RP; Hunter D; Blundell G; Pride NB Thorax; 1979 Oct; 34(5):637-46. PubMed ID: 316207 [TBL] [Abstract][Full Text] [Related]
7. Lung function of school children with low levels of alpha1-antitrypsin and tobacco smoke exposure. von Ehrenstein OS; von Mutius E; Maier E; Hirsch T; Carr D; Schaal W; Roscher AA; Olgemöller B; Nicolai T; Weiland SK Eur Respir J; 2002 Jun; 19(6):1099-106. PubMed ID: 12108863 [TBL] [Abstract][Full Text] [Related]
8. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial. Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG; Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936 [TBL] [Abstract][Full Text] [Related]
9. Changes in the forced expiratory spirogram in young male smokers. Walter S; Nancy NR; Collier CR Am Rev Respir Dis; 1979 May; 119(5):717-24. PubMed ID: 453697 [TBL] [Abstract][Full Text] [Related]
10. Alpha 1 antitrypsin heterozygotes (Pi type MZ). A longitudinal study of the risk of development of chronic air flow limitation. Horton FO; Mackenthun AV; Anderson PS; Patterson CD; Hammarsten JF Chest; 1980 Feb; 77(2 Suppl):261-4. PubMed ID: 6965633 [No Abstract] [Full Text] [Related]
11. Relationship between loss in parenchymal elastic recoil pressure and maximal airway narrowing in subjects with alpha1-antitrypsin deficiency. Cheung D; Schot R; Zwinderman AH; Zagers H; Dijkman JH; Sterk PJ Am J Respir Crit Care Med; 1997 Jan; 155(1):135-40. PubMed ID: 9001302 [TBL] [Abstract][Full Text] [Related]
12. Sensitivity of volume of isoflow in the detection of mild airway obstruction. Gelb AF; Molony PA; Klein E; Aronstam PS Am Rev Respir Dis; 1975 Sep; 112(3):401-5. PubMed ID: 1163893 [TBL] [Abstract][Full Text] [Related]
13. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population. Dahl M; Tybjaerg-Hansen A; Lange P; Vestbo J; Nordestgaard BG Ann Intern Med; 2002 Feb; 136(4):270-9. PubMed ID: 11848724 [TBL] [Abstract][Full Text] [Related]
14. The prevalence of alpha-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease. Shigeoka JW; Hall WJ; Hyde RW; Schwartz RH; Mudholkar GS; Speers DM; Lin CC Am Rev Respir Dis; 1976 Dec; 114(6):1077-84. PubMed ID: 1087539 [TBL] [Abstract][Full Text] [Related]
15. Alpha1-antitrypsin deficiency alleles and the Taq-I G-->A allele in cystic fibrosis lung disease. Mahadeva R; Westerbeek RC; Perry DJ; Lovegrove JU; Whitehouse DB; Carroll NR; Ross-Russell RI; Webb AK; Bilton D; Lomas DA Eur Respir J; 1998 Apr; 11(4):873-9. PubMed ID: 9623690 [TBL] [Abstract][Full Text] [Related]
16. Bronchial reactivity, smoking, and alpha1-antitrypsin. A population-based study of middle-aged men. Kabiraj MU; Simonsson BG; Groth S; Björklund A; Bülow K; Lindell SE Am Rev Respir Dis; 1982 Nov; 126(5):864-9. PubMed ID: 6983320 [TBL] [Abstract][Full Text] [Related]
17. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years. Piitulainen E; Mostafavi B; Tanash HA Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073 [TBL] [Abstract][Full Text] [Related]
18. Relation of protease inhibitor phenotypes to obstructive lung diseases in a community. Morse JO; Lebowitz MD; Knudson RJ; Burrows B N Engl J Med; 1977 May; 296(21):1190-4. PubMed ID: 300842 [TBL] [Abstract][Full Text] [Related]
19. Interrelationships between neutrophil elastase, serum alpha, -antitrypsin, lung function and chest radiography in patients with chronic airflow obstruction. Abboud RT; Rushton JM; Grzybowski S Am Rev Respir Dis; 1979 Jul; 120(1):31-40. PubMed ID: 313728 [TBL] [Abstract][Full Text] [Related]
20. Normal values and evaluation of forced end-expiratory flow. Morris JF; Koski A; Breese JD Am Rev Respir Dis; 1975 Jun; 111(6):755-62. PubMed ID: 1137244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]